Neoplasia/BPH

	A four-miRNA serum panel as a diagnostic biomarker for prostate cancer: an exploratory and validation study. Front Oncol Yang Z, Lai Z, Xie J, Chen S, Ge Z, Lai Y, Li H. PMID: 42577108 [PubMed - in process]
	Triplet Therapy (Androgen Deprivation Therapy + Darolutamide + Biweekly Docetaxel) for High-risk Metastatic Castration-sensitive Prostate Cancer (TRIC Study): A Study Protocol for Open-labelled Single-Arm Phase II Clinical Trial. JMA J Iwamoto H, Hori T, Inaba T, Nakagawa R, Kamijima T, Kano H, Makino T, Naito R, Yaegashi H, Nohara T, Shigehara K, Izumi K, Mizokami A. PMID: 42577021 [PubMed]
	Metastasis-directed therapy in oligoprogressive prostate cancer: current evidence and future directions. Ann Palliat Med Wang JH, Huang D, Amoateng EJ, Tipirneni A, Zhang H, Bylund K, Cummings M, Tran PT, Deek MP, Sutera PA. PMID: 42576472 [PubMed - indexed for MEDLINE]
	Clinical Outcomes of Single-Dose Flomoxef Prophylaxis for Transrectal Prostate Biopsy: A Single-Center Study of 834 Cases. Int J Urol Sugihara N, Sawada T, Arai H, Nishida K, Ohnishi T, Watanabe R, Nishimura K, Fukumoto T, Miura N, Miyauchi Y, Saika T. PMID: 42576438 [PubMed - indexed for MEDLINE]
	Validation of the NCCN Subclassification for Intermediate-Risk Prostate Cancer in a Japanese Radical Prostatectomy Cohort: Results From the MICAN Study. Int J Urol Oono T, Terashita M, Mori S, Oka A, Matsuzaki S, Yano A, Matsumura M, Ninomiya I, Shinomori K, Ogawa T, Onishi T, Shirato A, Watanabe Y, Hashine K, Yamashita N, Watanabe R, Miura N, Saika T. PMID: 42576432 [PubMed - indexed for MEDLINE]
	Natural History, Tumor Growth Kinetics, and Renal Functional Outcomes of Sporadic Bilateral Multifocal Papillary Renal Cell Carcinoma: A 25-yr Prospective Cohort Study. Eur Urol Oncol Fu H, Blachman-Braun R, Loebach L, Owens-Walton J, Millan B, Michael P, Patel M, Vocke CD, Ricketts CJ, Schmidt LS, Gautam R, Merino MJ, Gurram S, Marston Linehan W, Ball MW. PMID: 42575757 [PubMed - as supplied by publisher]
	Exploring the Putative Role of EGFR in Prostate Cancer: Interactions with Androgen and Estrogen Receptors. J Steroid Biochem Mol Biol Gonçalves GM, Souza DS, Costa C, Oliveira M, Porto CS, Vicente CM. PMID: 42575475 [PubMed - as supplied by publisher]
	Building a Natural Language Processing Augmented Information Support System to Enhance Supportive Care for Patients With Prostate Cancer and Families: User-Centered, Iterative Approach. J Med Internet Res Song L, Wang X, Yu F, Zuo D, Ranzinger LH, Liss M, Tan HJ. PMID: 42574684 [PubMed - indexed for MEDLINE]
	Evaluation of Stimulated Raman Histology as a Novel Method for Pathologic Examination of Urothelial Carcinoma With Unprocessed, Fresh Bladder Cancer Tissue. Technol Cancer Res Treat Maisch P, Mühlberger M, Beck A, Schreen W, Mannas MP, Horsch C, Bolenz C. PMID: 42574263 [PubMed - indexed for MEDLINE]
	Disability Status and Prostate Cancer Screening Among US Men Aged 55 to 69 Years. JAMA Netw Open Nolazco JI, Iezzoni LI, Chen EC, Park ER, Wang W, Leapman MS, Alkhatib KY, Teoh JYC, Cole AP, Mossanen M, Lay AH, Bartels SJ, Kibel AS, Feldman AS, Chang SL. PMID: 42574016 [PubMed - indexed for MEDLINE]
	Prostatic Artery Embolization: A Contemporary Review of Efficacy, Safety, and Expanding Clinical Indications. Curr Urol Rep Tawfellos G, Zillo C, Gaupp FL, Sanekommu G. PMID: 42573863 [PubMed - indexed for MEDLINE]
	Renal outcomes and compensatory hypertrophy in survivors of unilateral non-syndromic Wilms tumour: a single-centre cross-sectional study from a tertiary-care institution in India. Pediatr Surg Int Potturu M, Sehgal M, Sinha A, Jana M, Rangarajan K, Datta SK, Kumar R, Nilima N, Yadav DK, Goel P, Agarwala S, Dhua AK, Srinivas M, Gali D, Jain V. PMID: 42573811 [PubMed - indexed for MEDLINE]
	Multimodal artificial intelligence for prostate cancer imaging: workflow-relevant fusion of mpMRI, PSMA PET, ultrasound, and clinical data for diagnosis, local staging, and treatment personalization. Abdom Radiol (NY) Doniyor T, Jasur R, Gulnihol S, Dilorom S, Aliev S, Kenjaev Y. PMID: 42573772 [PubMed - as supplied by publisher]
	Preoperative membranous urethral length predicts quality-of-life recovery and urinary incontinence after holmium enucleation of the prostate. World J Urol Nagasaki N, Sadahira T, Tsuboi I, Watanabe T, Kanemoto S, Tominaga Y, Katayama S, Nishimura S, Bekku K, Watanabe M, Watanabe T, Araki M. PMID: 42573750 [PubMed - indexed for MEDLINE]
	ASO Visual Abstract: Risk-adapted use of adjuvant systemic therapy after nephrectomy for renal cell carcinoma: a population-based study in the post-approval era. Ann Surg Oncol Filzmayer M, Petix M, Quarta L, Orlandi F, Goyal JA, Carmignani L, Briganti A, Micali S, Shariat SF, Wenzel M, Heß-Busch Y, Humke C, Saad F, Chun FK, Karakiewicz PI. PMID: 42573667 [PubMed - as supplied by publisher]
	Impact of structured reporting on interpretability of PSMA PET/CT in prostate cancer staging-towards standardised clinical implementation. Eur Radiol Exp Biechele G, Schnitzer M, Göbel R, Bauer N, Fouladgar ST, Herr F, Zaganjori M, Holzgreve A, Klimek K, Werner R, Cyran C, Ricke J, Rübenthaler J, Geyer T. PMID: 42573660 [PubMed - indexed for MEDLINE]
	Epidemiology and Overall Survival of De Novo and Transformed Neuroendocrine Prostate Cancer: A Two-Nation Population-Based Study of 1,465 Patients from the United States and England. Endocr Relat Cancer Choi S, Mortagy M, Tan KS, White BE, Paisey S, Abdelhameed A, Rous B, Ramage J. PMID: 42573114 [PubMed - as supplied by publisher]
	How low do you need to go? Association between various prostate-specific antigen response measures and clinical outcomes in metastatic castration-sensitive prostate cancer in the Veterans Health Administration data. Cancer Freedland SJ, Gao W, Touya M, Yang H, Russell D, Chen J, Chen G, Ivanova JI. PMID: 42572469 [PubMed - indexed for MEDLINE]
	Effect of Implementing Population-Based Prostate-Specific Antigen Screening on Testing Rates and Prostate Cancer Overdiagnosis in England: A Statistical Modelling Study. Int J Cancer Vickers AJ, Kasivisvanathan V, Brentnall AR. PMID: 42572363 [PubMed - as supplied by publisher]
	Radiofrequency Ablation for Recurrent Renal Tumors After Partial Nephrectomy: A Retrospective Cohort Study of Technical Considerations and Oncologic Outcomes. J Endourol Yang J, Wang X, Li Z, Zhang Z, Zhang M, Sun Z, Yao K, Li D, Li X, Zhang K. PMID: 42572240 [PubMed - as supplied by publisher]

Articles 1 - 20 / 190380

Page 1 of 9519



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy